TCL Archive BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal June 21, 2002
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei May 22, 1992